Trending Stock News

Atomera (ATOM) Reaches $7.65 52-Week High; Metlife Has 1.02 Sentiment

The stock of Atomera Incorporated (NASDAQ:ATOM) hit a new 52-week high and has $8.26 target or 8.00% above today’s $7.65 share price. The 6 months bullish chart indicates low risk for the $93.05 million company. The 1-year high was reported on Mar, 14 by If the $8.26 price target is reached, the company will be worth $7.44M more. The stock increased 8.85% or $0.6221 during the last trading session, reaching $7.6521. About 561,676 shares traded or 566.82% up from the average. Atomera Incorporated (NASDAQ:ATOM) has 0.00% since March 14, 2017 and is . It has underperformed by 16.70% the S&P500.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. The company has market cap of $49.02 billion. It operates in six divisions: U.S.; Asia; Latin America; Europe, the Middle East, and Africa; MetLife Holdings; and Brighthouse Financial. It has a 13.08 P/E ratio. The firm offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, and critical illness insurance products; vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only and private floating rate funding agreements; and account guaranteed, separate account guaranteed, and trust guaranteed interest contracts.

Atomera Incorporated, a semiconductor materials and intellectual property licensing company, engages in developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company has market cap of $93.05 million. The Company’s lead technology is Mears Silicon Technology, or MST, a thin film of reengineered silicon that could be applied as a transistor channel enhancement to complementary metal-oxide semiconductor type transistors in the semiconductor industry. It currently has negative earnings. The firm was formerly known as Mears Technologies, Inc. and changed its name to Atomera Incorporated in January 2016.

Poplar Forest Capital Llc holds 4.33% of its portfolio in MetLife, Inc. for 961,272 shares. Lumbard & Kellner Llc owns 141,753 shares or 4.01% of their US portfolio. Moreover, Matrix Asset Advisors Inc Ny has 3.74% invested in the company for 436,611 shares. The Massachusetts-based Cutler Capital Management Llc has invested 3.72% in the stock. Groesbeck Investment Management Corp Nj, a New Jersey-based fund reported 98,537 shares.

The stock increased 0.39% or $0.185 during the last trading session, reaching $47.285. About 1.11 million shares traded. MetLife, Inc. (MET) has risen 13.92% since March 14, 2017 and is uptrending. It has underperformed by 2.78% the S&P500.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on May, 2. They expect $1.18 earnings per share, down 19.18% or $0.28 from last year’s $1.46 per share. MET’s profit will be $1.22 billion for 10.02 P/E if the $1.18 EPS becomes a reality. After $1.11 actual earnings per share reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 6.31% EPS growth.

Leave a Reply

Your email address will not be published. Required fields are marked *